AGP Executive Report
Last update: 10 hours agoCorporate Moves: Curaleaf has launched a hostile takeover bid for Aurora Cannabis, offering $4 per Aurora share (cash + stock) and signaling a major shake-up for investors watching consolidation in the cannabis market. Public Health: A CDC report finds ED visits for cannabis hyperemesis syndrome jumped after a new CHS-specific ICD-10 code took effect in Oct. 2025, pointing to a likely undercount of CHS before. Medical Research: Lab studies suggest some cannabinoids may make glioblastoma cells less vulnerable to chemotherapy and radiation, raising fresh questions about how CBD/other compounds could interact with cancer treatment. Regulation & Retail: Nevada City is set to revisit cannabis rules, including easing limits on temporary events and allowing more flexibility for delivery-only retail and consumption-lounge setups. Local Industry Spotlight: Noiré Dispensary is rolling out a curated, education-forward menu plus expanded delivery across New Jersey counties, leaning into “plain language” cannabis science for shoppers. Aviation & Drug Testing: India’s aviation probe into an Air India Phuket–Delhi incident includes reports the pilot tested positive for marijuana in a confirmatory test, with crew pulled from flying duties pending investigation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
